At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Andrew B. Lassman, MD, of Columbia University Medical Center, New York, NY, discusses the results of the randomised phase 3 NCCTG N0574 (Alliance) trial of whole brain radiation therapy in addition to stereotactic radiosurgery in patients with 1 to 3 brain metastases.
>